This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
New Horizon Health Croissance future
Future contrôle des critères 5/6
New Horizon Health is forecast to grow earnings and revenue by 60.4% and 20.5% per annum respectively. EPS is expected to grow by 60% per annum. Return on equity is forecast to be 19.5% in 3 years.
Informations clés
60.4%
Taux de croissance des bénéfices
60.0%
Taux de croissance du BPA
| Healthcare croissance des bénéfices | 19.4% |
| Taux de croissance des recettes | 20.5% |
| Rendement futur des capitaux propres | 19.5% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 12 Jun 2024 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 3,732 | 825 | 309 | N/A | 1 |
| 12/31/2025 | 3,612 | 546 | -60 | N/A | 3 |
| 12/31/2024 | 2,835 | 266 | -383 | N/A | 3 |
| 12/31/2023 | 1,843 | 10 | -235 | N/A | 3 |
| 6/30/2023 | 1,362 | 112 | -630 | -521 | N/A |
| 3/31/2023 | 1,063 | 16 | -548 | -467 | N/A |
| 12/31/2022 | 765 | -79 | -466 | -413 | N/A |
| 9/30/2022 | 580 | -169 | -483 | -434 | N/A |
| 6/30/2022 | 394 | -259 | -500 | -455 | N/A |
| 3/31/2022 | 304 | -1,672 | -446 | -405 | N/A |
| 12/31/2021 | 213 | -3,085 | -392 | -355 | N/A |
| 9/30/2021 | 164 | -3,244 | -325 | -289 | N/A |
| 6/30/2021 | 104 | -3,128 | -243 | -210 | N/A |
| 3/31/2021 | 87 | -1,958 | -199 | -171 | N/A |
| 12/31/2020 | 71 | -789 | -156 | -132 | N/A |
| 9/30/2020 | 58 | -578 | -159 | -138 | N/A |
| 6/30/2020 | 56 | -645 | -104 | -77 | N/A |
| 3/31/2020 | 57 | -375 | -106 | -76 | N/A |
| 12/31/2019 | 58 | -106 | -109 | -75 | N/A |
| 12/31/2018 | 19 | -225 | -73 | -56 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 6606's forecast earnings growth (60.4% per year) is above the savings rate (2.2%).
Bénéfices vs marché: 6606's earnings (60.4% per year) are forecast to grow faster than the Hong Kong market (11.6% per year).
Croissance élevée des bénéfices: 6606's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 6606's revenue (20.5% per year) is forecast to grow faster than the Hong Kong market (7.9% per year).
Croissance élevée des revenus: 6606's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 6606's Return on Equity is forecast to be low in 3 years time (19.5%).